Avivia is an independent specialized pharmaceutical development company engaged in drug repositioning, repurposing and reformulation.

Our expertise and capabilities are centered around the development of value-added generic drugslife cycle management of branded drug products, and complex formulation and CMC development of new drug products (NCE). We operate a hybrid business model combining CRO service activities with internal product development programs, whereby in both cases, we approach ‘development’ as not just offering a technical solution but always part of a broader product-oriented strategy. Welcome to Avivia and we hope to be in touch soon!